Chemoendocrine therapy versus tamoxifen with ovarian function suppression in women with node-positive breast cancer. Hwang YH, Lee SB, Kim J, Chung IY, et al. Breast Cancer Res Treat 2026;220:31.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hwang YH, Lee SB, Kim J, Chung IY, et al. Chemoendocrine therapy versus tamoxifen with ovarian function suppression in women with node-positive breast cancer. Breast Cancer Res Treat 2026;220:31.
PMID: 43004037